EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Glucosylated Hybrid TiO 2 /Polymer Nanomaterials for Actively Targeted Sonodynamic Therapy of Cancer

Ivan Zlotver, Alejandro Sosnik iD

Small · 2024-01 · 20 (4)

DOI: 10.1002/smll.202305475 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, online erschienen am 15.09.2023. Verfasst von Ivan Zlotver und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Pharmaceutical Nanomaterials Science, Department of Materials Science and Engineering, Technion-Israel Institute of Technology, Haifa, …. Hauptthemen laut MEDLINE: Ultrasonic Therapy, Nanoparticles, Rhabdomyosarcoma. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Israel Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sonodynamic therapy (SDT) is an anti‐cancer therapeutic strategy based on the generation of reactive oxygen species (ROS) upon local ultrasound (US) irradiation of sono‐responsive molecules or nanomaterials that accumulate in the tumor. In this work, the sonodynamic efficiency of sono‐responsive hybrid nanomaterials composed of amorphous titanium dioxide and an amphiphilic poly(ethylene oxide)‐ b ‐poly(propylene oxide) block copolymer is synthesized, fully characterized, and investigated both in vitro and in vivo. The modular and versatile synthetic pathway enables the control of the nanoparticle size between 30 and 300 nm (dynamic light scattering) and glucosylation of the surface for active targeting of tumors overexpressing glucose transporters. Studies on 2D and 3D rhabdomyosarcoma cell cultures reveal a statistically significant increase in the sonodynamic efficiency of glucosylated hybrid nanoparticles with respect to unmodified ones. Using a xenograft rhabdomyosarcoma murine model, it is demonstrated that by tuning the nanoparticle size and surface features, the tumor accumulation is increased by ten times compared to main off‐target clearance organs such as the liver. Finally, the SDT of rhabdomyosarcoma‐bearing mice is investigated with 50‐nm glucosylated nanoparticles. Findings evidence a dramatic prolongation of the animal survival and tumor volumes 100 times smaller than those treated only with ultrasound or nanoparticles.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ultrasonic TherapyNanoparticlesRhabdomyosarcomaHumansAnimalsMiceUltrasonographyReactive Oxygen SpeciesPolymersCell Line, Tumor

Stichwörter der Autor:innen

active targetingglucose transportershybrid amorphous titanium dioxide/polymer nanomaterialssarcomassonodynamic therapy

Substanzen

Reactive Oxygen SpeciesPolymers

Autor:innen und Institutionen

  • Laboratory of Pharmaceutical Nanomaterials Science, Department of Materials Science and Engineering, Technion-Israel Institute of Technology, Haifa, 3200003, Israel.

ORCID-Profile: Alejandro Sosnik

Förderung

  • Israel Science Foundation

Zitieren

APA

Zlotver, I., & Sosnik, A. (2024). Glucosylated Hybrid TiO 2 /Polymer Nanomaterials for Actively Targeted Sonodynamic Therapy of Cancer. Small, 20(4). https://doi.org/10.1002/smll.202305475

Vancouver

Zlotver I, Sosnik A. Glucosylated Hybrid TiO 2 /Polymer Nanomaterials for Actively Targeted Sonodynamic Therapy of Cancer. Small. 2024;20(4). doi:10.1002/smll.202305475

BibTeX
@article{Zlotver2024,
  author = {Zlotver, Ivan and Sosnik, Alejandro},
  title = {Glucosylated Hybrid TiO 2 /Polymer Nanomaterials for Actively Targeted Sonodynamic Therapy of Cancer},
  journal = {Small},
  year = {2024},
  volume = {20},
  number = {4},
  doi = {10.1002/smll.202305475}
}
Kostenlos starten →